Skip to content

Clinical Study on Repetitive Transcranial Magnetic Stimulation for the Treatment of Sleep Disorders in Parkinson's Disease

Clinical Study on Repetitive Transcranial Magnetic Stimulation for the Treatment of Sleep Disorders in Parkinson's Disease

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100640
Enrollment
Unknown
Registered
2025-04-11
Start date
2025-05-01
Completion date
Unknown
Last updated
2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinon's disease

Interventions

Sham stimulation group:rTMS sham stimualtion
rTMS group:low frequency rTMS
cTBS group:continuous ? burst stimulation

Sponsors

the Second Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1 Age of presentation >=18 years old; 2 Han nationality; 3 Diagnosis of clinically confirmed Parkinson's disease according to the 2015 MDS PD diagnostic criteria; Patients who have received dopaminergic drug therapy for a course of >=30 days and maintain the original drug regimen during the treatment period; 4. Complete the signing of the informed consent form; 5 Pittsburgh sleep quality index (PSQI) score >5.

Exclusion criteria

Exclusion criteria: 1 Is using any type of sleep aid, sedative, antidepressant, or other psychoactive medication; 2. There are obvious stressful or stressful events recently, such as widowhood, death of a relative, unemployment, etc.; 3. Contraindications to transcranial magnetic stimulation, including previous severe head trauma or cerebral surgical intervention, history of epilepsy, active tumor, intracranial hypertension, ferromagnetic device implantation such as pacemaker, neurostimulator, etc.; 4 History of receiving any form of transcranial magnetic stimulation or transcranial electrical stimulation in the past 3 months; 5 Cognitive impairment (MMSE scale <22 points); 6. Unable to continue to cooperate with the study due to illness or personal reasons.

Design outcomes

Primary

MeasureTime frame
Clinical sleep parameter;Subjective sleep parameters;

Secondary

MeasureTime frame
EEG;Motor symptom;

Countries

China

Contacts

Public ContactZhuang Sheng

The Second Affiliated Hospital of Soochow University

13402582992@163.com+86 134 0258 2992

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026